{"id":680681,"date":"2023-12-11T18:24:02","date_gmt":"2023-12-11T18:24:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=680681"},"modified":"2023-12-11T18:24:02","modified_gmt":"2023-12-11T18:24:02","slug":"rna-analysis-market-worth-99-billion-by-2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/rna-analysis-market-worth-99-billion-by-2028_680681.html","title":{"rendered":"RNA Analysis Market worth $9.9 billion by 2028"},"content":{"rendered":"
\n
\"RNA<\/a><\/div>\n
\n
RNA analysis allows researchers to study the dynamic gene expression patterns in cells and tissues, providing valuable insights into how genes are regulated and how they respond to different stimuli, disease conditions, or treatments.<\/div>\n<\/div>\n<\/div>\n
In the near future, the RNA analysis industry is poised for unprecedented growth and innovation, driven by remarkable advancements in technology and research.<\/div>\n

RNA Analysis Market<\/a><\/strong> in terms of revenue was estimated to be worth $5.3 Billion in 2023 and is poised to reach $9.9 Billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global RNA analysis market is expected to grow at a CAGR of 13.4% during the forecast period. Growth in this market is driven by the growing R&D activities in the pharmaceutical industry, and growing government investments in the field of life science research. Moreover, the increasing research being undertaken with integrated omics studies contributes to the market.<\/p>\n

Download an Illustrative overview: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=240344576<\/a><\/strong><\/p>\n

The reagents\/consumables segment accounted for the largest share of the product & service segment in the RNA analysis market in 2022.<\/strong><\/p>\n

Based on product & service, the RNA analysis market is segmented into reagents\/consumables, instruments, software, and services. In 2022, the reagents\/consumables segment accounted for the largest share of the RNA analysis market. The large share of this segment is fueled by the increasing demand for omics-based therapeutics, expanding research and development activities, and the availability of various RNA analysis reagents in the market.<\/p>\n

The PCR segment accounted for the largest share of the technology segment in the RNA analysis market in 2022.<\/strong><\/p>\n

Based on technology, the RNA analysis market is segmented into PCR, sequencing, microarrays, and RNA interference. The PCR segment accounted for the largest share in the RNA analysis market in 2022. PCR is associated with several advantages, such as ease of operation, and short production cycles. These advantages support the growth of the PCR in the RNA analysis segment.<\/p>\n

Asia Pacific is likely to grow at the highest growth rate during the forecast period.<\/strong><\/p>\n

Based on the region The global RNA analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the RNA analysis market during the forecast period. The growth of the pharmaceuticals market in the region is primarily driven by the increasing prevalence of chronic diseases, the rising disposable incomes, the growing focus on personalized medicine, and the increasing government support for genomics and proteomics.<\/p>\n

Request Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=240344576<\/a><\/strong><\/p>\n

RNA Analysis Market Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n

    \n
  1. Growing demand for personalized medicine<\/li>\n<\/ol>\n

    Restraints:<\/strong><\/p>\n

      \n
    1. High capital investments<\/li>\n<\/ol>\n

      Opportunities:<\/strong><\/p>\n

        \n
      1. Opportunities in Emerging Countries<\/li>\n<\/ol>\n

        Challenges:<\/strong><\/p>\n

          \n
        1. Data management in transcriptomics research<\/li>\n<\/ol>\n

          Key Market Players:<\/strong><\/p>\n

          The prominent players operating in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), and Eurofins Scientific (Luxembourg).<\/p>\n

          Get 10% Free Customization on this Report: https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=240344576<\/a><\/strong><\/p>\n

          Media Contact<\/span>
          Company Name:<\/strong>           MarketsandMarkets\u2122 Research Private Ltd.<\/a>
          Contact Person:<\/strong> Mr. Aashish Mehra
          Email:<\/strong>           Send Email<\/a>
          Phone:<\/strong> 18886006441
          Address:<\/strong>630 Dundee Road Suite 430
          City:<\/strong> Northbrook
          State:<\/strong> IL 60062
          Country:<\/strong> United States
          Website:<\/strong>           https:\/\/www.marketsandmarkets.com\/Market-Reports\/trancriptomics-market-240344576.html<\/a><\/p>\n

          <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

          RNA analysis allows researchers to study the dynamic gene expression patterns in cells and tissues, providing valuable insights into how genes are regulated and how they respond to different stimuli, disease conditions, or treatments. In the near future, the RNA … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-680681","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=680681"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=680681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=680681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=680681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}